Merge Healthcare Sets Third Quarter 2009 Earnings Call

Third quarter earnings results will be published before the market opens on October 29th. The public earnings call and web cast will follow at 4:15 PM EDT to review financial results for the third quarter of 2009, and to provide an update on business operations and strategy. Immediately following, there will be a question and answer session. Investors will have the opportunity to listen to the conference call via telephone or over the Internet at Merge Healthcare Web Cast.

To access the call, dial 800.221.2015 (US and Canada) or 706.634.2159 (International). The Conference ID Number to reference is 35849235. A replay via the Internet or telephone will be available shortly after the call at http://www.merge.com/investor/conferencecall.asp.

Merge Healthcare Incorporated develops software solutions that automate healthcare data and diagnostic workflow to create a more comprehensive electronic record of the patient experience. Merge products, ranging from standards-based development toolkits to fully integrated clinical applications, have been used by healthcare providers worldwide for over 20 years. Additional information can be found at www.merge.com.

This news release contains "forward-looking statements," including statements which are related to future, not past, events. Forward-looking statements usually describe expected future business and financial outlook or performance, and often contain words such as "will," "believes," "intends," "anticipates," "expects," "plans," "seeks," "see" and similar expressions. Forward-looking statements, by their nature, address matters that are, to varying degrees, uncertain and subject to various known and unknown risks. For Merge, particular uncertainties and risks that could cause actual results to differ materially from post-merger forward-looking statements include: the consummation and the successful integration of etrials into Merge; possible accounting adjustments and revisions to its current preliminary expectations as to the results the Company will report for second quarter financial results; market acceptance and performance of its products and services; the impact of competitive products and pricing; possible delays in the implementation of its managed services offering; the risks and effects of its recent changes in its executive and Board leadership, including the costs and expenses related to severance payments made to departing officers; the risks and effects of its recent securities issues, including the issuance of certain senior secured notes; the past restatement of its financial statements and other actions that may be taken or required as a result of such restatement; its ability to generate sufficient cash from operations to meet future operating, financing and capital requirements, including repayment obligations with respect to its outstanding indebtedness; risks associated with its prior delays in filings with the SEC or its ability to continue to meet the listing requirements of The NASDAQ Stock Market; the costs, risks and effects of various pending legal proceedings and investigations, including the formal investigation being conducted by the Securities and Exchange Commission and the pending settlements of certain class action and derivative lawsuits; and other risk factors detailed in its filings with the Securities and Exchange Commission. These uncertainties and risks may cause its actual future results to be materially different than those expressed in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Merge does not undertake any obligation to update such forward-looking statements or any of such risks, uncertainties and other factors.

SOURCE: Merge Healthcare

Merge Healthcare 
Media Contact: 
Julie Pekarek 
Chief Marketing Officer 
414.977.4254 
jpekarek@merge.com